NCT04352439View on ClinicalTrials.gov

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

PHASE4CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

August 8, 2020

Primary Completion Date

March 2, 2022

Study Completion Date

March 2, 2022

Conditions

Venous ThromboembolismOvarian Cancer

Interventions

DRUG

Aspirin

81 mg aspirin daily

Trial Locations (2)

27710

Duke University Hospital, Durham

34329

Sarasota Memorial HealthCare System, Sarasota

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER